These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21930290)

  • 21. Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination Strategies.
    Li H; Tsui TY; Ma W
    Int J Mol Sci; 2015 Aug; 16(8):19518-36. PubMed ID: 26295227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced intracellular siRNA delivery using bioreducible lipid-like nanoparticles.
    Wang M; Alberti K; Varone A; Pouli D; Georgakoudi I; Xu Q
    Adv Healthc Mater; 2014 Sep; 3(9):1398-403. PubMed ID: 24574196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
    Zhong J; Huang HL; Li J; Qian FC; Li LQ; Niu PP; Dai LC
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics.
    Maier MA; Jayaraman M; Matsuda S; Liu J; Barros S; Querbes W; Tam YK; Ansell SM; Kumar V; Qin J; Zhang X; Wang Q; Panesar S; Hutabarat R; Carioto M; Hettinger J; Kandasamy P; Butler D; Rajeev KG; Pang B; Charisse K; Fitzgerald K; Mui BL; Du X; Cullis P; Madden TD; Hope MJ; Manoharan M; Akinc A
    Mol Ther; 2013 Aug; 21(8):1570-8. PubMed ID: 23799535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels.
    Hassani Z; Lemkine GF; Erbacher P; Palmier K; Alfama G; Giovannangeli C; Behr JP; Demeneix BA
    J Gene Med; 2005 Feb; 7(2):198-207. PubMed ID: 15515135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics.
    Akinc A; Zumbuehl A; Goldberg M; Leshchiner ES; Busini V; Hossain N; Bacallado SA; Nguyen DN; Fuller J; Alvarez R; Borodovsky A; Borland T; Constien R; de Fougerolles A; Dorkin JR; Narayanannair Jayaprakash K; Jayaraman M; John M; Koteliansky V; Manoharan M; Nechev L; Qin J; Racie T; Raitcheva D; Rajeev KG; Sah DW; Soutschek J; Toudjarska I; Vornlocher HP; Zimmermann TS; Langer R; Anderson DG
    Nat Biotechnol; 2008 May; 26(5):561-9. PubMed ID: 18438401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic SiRNA Delivery: Progress and Prospects.
    Roberts TC; Ezzat K; El Andaloussi S; Weinberg MS
    Methods Mol Biol; 2016; 1364():291-310. PubMed ID: 26472459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo.
    Hassler MR; Turanov AA; Alterman JF; Haraszti RA; Coles AH; Osborn MF; Echeverria D; Nikan M; Salomon WE; Roux L; Godinho BMDC; Davis SM; Morrissey DV; Zamore PD; Karumanchi SA; Moore MJ; Aronin N; Khvorova A
    Nucleic Acids Res; 2018 Mar; 46(5):2185-2196. PubMed ID: 29432571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of PLGA-Lipid Hybrid Nanoparticles for siRNA Delivery Using the Emulsion Method PLGA-PEG-Lipid Nanoparticles for siRNA Delivery.
    Wang L; Griffel B; Xu X
    Methods Mol Biol; 2017; 1632():231-240. PubMed ID: 28730443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics.
    Springer AD; Dowdy SF
    Nucleic Acid Ther; 2018 Jun; 28(3):109-118. PubMed ID: 29792572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retro-inverso cell-penetrating peptide for siRNA delivery.
    Vaissière A; Aldrian G; Konate K; Lindberg MF; Jourdan C; Telmar A; Seisel Q; Fernandez F; Viguier V; Genevois C; Couillaud F; Boisguerin P; Deshayes S
    J Nanobiotechnology; 2017 Apr; 15(1):34. PubMed ID: 28454579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RNAi in functional genomics.
    Scherr M; Eder M
    Curr Opin Mol Ther; 2004 Apr; 6(2):129-35. PubMed ID: 15195923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in RNAi therapeutic delivery to leukocytes using lipid nanoparticles.
    Ramishetti S; Landesman-Milo D; Peer D
    J Drug Target; 2016 Nov; 24(9):780-786. PubMed ID: 27030014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The spacer arm length in cell-penetrating peptides influences chitosan/siRNA nanoparticle delivery for pulmonary inflammation treatment.
    Jeong EJ; Choi M; Lee J; Rhim T; Lee KY
    Nanoscale; 2015 Dec; 7(47):20095-104. PubMed ID: 26568525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multifunctional peptide-lipid nanocomplexes for efficient targeted delivery of DNA and siRNA into breast cancer cells.
    Wan Y; Dai W; Nevagi RJ; Toth I; Moyle PM
    Acta Biomater; 2017 Sep; 59():257-268. PubMed ID: 28655658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-based Vehicles for siRNA Delivery in Biomedical Field.
    Li T; Huang L; Yang M
    Curr Pharm Biotechnol; 2020; 21(1):3-22. PubMed ID: 31549951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.